Outsourced Drug Development Solutions
-
Premium Tools For Diabetes Research
8/5/2025
Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.
-
Psychedelics: Drug Development Capabilities
10/30/2023
Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.
-
Bioprocess Courses And Services
8/5/2022
Learn how our courses and services provide access to science experts that will guide your process and engineering needs and suggest optimization strategies to support an efficient scale-up of the process.
-
GLP-1 Receptor Agonist Solutions
9/2/2025
The journey of a GLP-1 receptor agonist (GLP-1 RA) molecule is complex.
-
Multi-Mode Microplate Reader For Assay Flexibility
6/21/2023
Precise optics, fluidic transfer, and assay flexibility on one integrated microplate reader.
-
Resins Selection Guide
7/21/2022
Learn how to select the right media resins for your application based on various parameters such as particle size, molecular weight, fractionation ranges and pH.
-
Curia R&D Pipeline Overview
2/18/2026
This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.
-
Drug Product Development And Manufacturing Services
3/17/2025
Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.
-
A CDMO With Oral Solid Dose And Sterile Injectable Expertise
6/6/2022
Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.
-
Immunoassays And LC-MS
10/20/2025
Explore immunoassays and LC-MS kits for over 30 clinical areas, each with detailed specifications and broad sample compatibility for precise, high-throughput biomarker analysis.